60 questions about SCLC with Dr. Greg Kalemkerian Part 2
Roquefort Therapeutics Acquires Global Rights to TACC3 Inhibitor AO-252 in £31.9M Deal, Pivoting to Clinical-Stage Oncology
15 Posts Not To Miss from ESGO 2026
LITESPARK-022 Update: Adjuvant Belzutifan + Pembrolizumab in High-Risk Clear Cell Renal Cell Carcinoma
MSK Awards and Appointments January 2026
Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors
Guru Sonpavde: Early Success With EV and FGFR Inhibitor in Bladder Cancer Patients
15 Posts Not To Miss From ASCO GU 2026
The webinar "Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies" is a high-level clinical session scheduled for March 9, 2026, at 18:00 CET. Serving as the second installment […]
The webinar titled "Escalation or de-escalation? Strategies in HER2+ breast cancer treatment" is scheduled to take place on April 23, 2026, at 18:00 CEST. Organized by OncoCorner and Sharing Progress […]
Leading innovation for better outcomes and performance in cancer care is a one-day, onsite event organized by Sharing Progress in Cancer Care (SPCC), scheduled for May 9, 2026, in Milan, […]
The Improving Outcomes in MEC: Clinical Evidence, Trial Insights and the Patient Perspective onsite event is scheduled for June 25, 2026, in Melbourne, Australia. Organized by Sharing Progress in Cancer Care (SPCC) under the Supportive Care and Integrative Oncology category, this session focuses on Mucoepidermoid Carcinoma (MEC). The program is designed to bridge the gap […]
